New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) in Patients With Asthma

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Asthma
Interventions
DRUG

Fluticasone propionate/formoterol fumarate

Trial Locations (28)

Unknown

Research Site, Berlin

Research Site, Hamburg

Research Site, Mainz

Research Site, Rudersdorf

Research Site, Solingen

Research Site, Budapest

Research Site, Deszk

Research Site, Kecskemét

Research Site, Miskolc

Research Site, Mosonmagyaróvár

Research Site, Bialystok

Research Site, Gdansk

Research Site, Krakow

Research Site, Lodz

Research Site, Wroclaw

Research Site, Bucharest

Research Site, Birmingham

Research Site, Carrickfergus

Research Site, Chippenham

Research Site, Cottingham

Research Site, Coventry

Research Site, Downpatrick

Research Site, Heywood

Research Site, Manchester

Research Site, Sheffield

Research Site, Solihull

Research Site, Sunbury-on-Thames

Research Site, Swindon Wilts

All Listed Sponsors
lead

SkyePharma AG

INDUSTRY

NCT00394121 - New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) in Patients With Asthma | Biotech Hunter | Biotech Hunter